Breaking News

Tweet TWEET

Hansen Medical to Present at Barclays Select Series 2013: Select Growth Conference

Hansen Medical to Present at Barclays Select Series 2013: Select Growth 
Conference 
MOUNTAIN VIEW, CA -- (Marketwired) -- 11/11/13 --  Hansen Medical,
Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today
announced that President and CEO, Bruce Barclay, is scheduled to
present at the Barclays Select Series 2013: Select Growth Conference.
The conference is being held November 18 - 20, 2013 in New York, NY.
Hansen Medical is scheduled to present on Monday, November 18, 2013
at 9:05 a.m. Eastern Time. 
Hansen Medical will provide a live webcast of the audio presentation.
Interested parties may access the live webcast by visiting the
investor relations section of Hansen Medical's web site at
www.hansenmedical.com. A replay of the webcast will be available at
the site after the presentation. 
About Hansen Medical, Inc.  
Hansen Medical, Inc., based in Mountain View, California, is a global
leader in intravascular robotics, developing products and technology
designed to enable the accurate positioning, manipulation and control
of catheters and catheter-based technologies. The Company's
Magellan(TM) Robotic System, 9Fr Magellan(TM) Robotic Catheter and
related accessories, which are intended to facilitate navigation to
anatomical targets in the peripheral vasculature and subsequently
provide a conduit for manual placement of therapeutic devices, have
undergone both CE marking and 510(k) clearance and are commercially
available in the European Union, and the U.S. In the European Union,
the Company's Sensei(R) X Robotic Catheter System and Artisan(R) and
Artisan Extend(R) Control Catheters are cleared for use during
electrophysiology (EP) procedures, such as guiding catheters in the
treatment of atrial fibrillation (AF), and the Lynx(R) Robotic
Ablation Catheter is cleared for the treatment of AF. This robotic
catheter system is compatible with fluoroscopy, ultrasound, 3D
surface map and patient electrocardiogram data. In the U.S., the
Company's Sensei X Robotic Catheter System and Artisan and Artisan
Extend Control Catheters are cleared by the U.S. Food and Drug
Administration for manipulation and control of certain mapping
catheters in EP procedures. In the U.S., the Sensei X Robotic
Catheter System is not approved for use in guiding ablation
pro
cedures; this use remains experimental. The U.S. product labeling
therefore provides that the safety and effectiveness of the Sensei X
Robotic Catheter System and Artisan and Artisan Extend Control
Catheter for use with cardiac ablation catheters in the treatment of
cardiac arrhythmias, including AF, have not been established.
Additional information can be found at www.hansenmedical.com. 
Forward-Looking Statements 
Hansen Medical's presentation will contain forward-looking statements
regarding, among other things, statements relating to goals, plans,
objectives, milestones and future events. All statements, other than
statements of historical fact, are statements that could be deemed
forward-looking statements, including statements containing the words
"plan," "expects," "potential," "believes," "goal," "estimate,"
"anticipates," and similar words. These statements are subject to
risks, uncertainties, changes in circumstances and other factors that
may cause actual results to differ materially from the information
expressed or implied by forward-looking statements. Important factors
that could cause actual results to differ materially from those
indicated by forward-looking statements are described in the "Risk
Factors" section of the Company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 2013 filed with the SEC on November
8, 2013 and the risks discussed in our other reports file
d with the
SEC. Given these uncertainties, you should not place undue reliance
on the Company's forward-looking statements. Hansen Medical
undertakes no obligation to revise or update its forward-looking
statements to reflect events or circumstances in the future, even if
new information becomes available.  
Hansen Medical, Heart Design (Logo), Hansen Medical (with Heart
Design), Sensei and Lynx are registered trademarks, and Magellan and
NorthStar are trademarks of Hansen Medical, Inc. in the United States
and other countries. 
Investor Contacts:
Peter J. Mariani
Chief Financial Officer
Hansen Medical, Inc. 
650.404.5800  
FTI Consulting, Inc.
Brian Ritchie
212.850.5683 
brian.ritchie@fticonsulting.com 
John Capodanno
212.850.5705
John.capodanno@fticonsulting.com